X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (14) 14
male (13) 13
peripheral vascular disease (11) 11
animals (9) 9
signal-transduction pathway (9) 9
rabbits (8) 8
hematology (7) 7
iloprost - pharmacology (7) 7
red blood cell (7) 7
adult (6) 6
cyclic amp - metabolism (6) 6
erythrocytes (6) 6
erythrocytes - metabolism (6) 6
female (6) 6
g-protein g (6) 6
middle aged (6) 6
physiology (6) 6
cardiac & cardiovascular systems (5) 5
erythrocytes - drug effects (5) 5
iloprost (5) 5
proteins (5) 5
adenosine triphosphatase (4) 4
adenosine triphosphate (4) 4
adenosine triphosphate - metabolism (4) 4
article (4) 4
articles (4) 4
complement (4) 4
diagnosis (4) 4
health aspects (4) 4
induced increases (4) 4
isoproterenol (4) 4
isoproterenol - pharmacology (4) 4
medicine, general & internal (4) 4
oxygen - metabolism (4) 4
phosphodiesterase inhibitors - pharmacology (4) 4
physiological aspects (4) 4
red-blood-cell (4) 4
research (4) 4
signal transduction - drug effects (4) 4
aged (3) 3
alternative pathway (3) 3
atp release (3) 3
camp (3) 3
cardiac myocytes (3) 3
care and treatment (3) 3
cells (3) 3
cyclic nucleotide phosphodiesterases, type 3 - metabolism (3) 3
eculizumab (3) 3
epoprostenol - analogs & derivatives (3) 3
erythrocyte membrane - drug effects (3) 3
hemolytic-uremic syndrome (3) 3
immunology (3) 3
kinases (3) 3
phosphodiesterases (3) 3
receptors, epoprostenol (3) 3
receptors, prostaglandin - metabolism (3) 3
smooth-muscle (3) 3
t cell receptors (3) 3
abridged index medicus (2) 2
adenosine triphosphate - secretion (2) 2
adenosine-triphosphate (2) 2
adenylate-cyclase (2) 2
adenylyl cyclase (2) 2
adrenergic beta-agonists - pharmacology (2) 2
ahus (2) 2
anticoagulants (2) 2
antihypertensive agents - pharmacology (2) 2
arterioles - metabolism (2) 2
autoimmunity (2) 2
beta-adrenergic receptors (2) 2
biochemical research methods (2) 2
cancer (2) 2
carbenoxolone (2) 2
carbenoxolone - pharmacology (2) 2
compartmentalized phosphodiesterases (2) 2
connexins - antagonists & inhibitors (2) 2
connexins - metabolism (2) 2
cricetinae (2) 2
cross-talk (2) 2
cyclic nucleotide phosphodiesterases, type 4 - metabolism (2) 2
cyclic-nucleotide phosphodiesterase (2) 2
development and progression (2) 2
discontinuation (2) 2
disease (2) 2
epoprostenol - pharmacology (2) 2
erythrocyte (2) 2
erythrocyte membrane - enzymology (2) 2
erythrocyte membrane - metabolism (2) 2
erythrocytes - cytology (2) 2
erythrocytes - enzymology (2) 2
genetic aspects (2) 2
hemolytic uremic syndrome (2) 2
hypoxia (2) 2
impact (2) 2
inhibitor eculizumab (2) 2
mass spectrometry (2) 2
medicine, research & experimental (2) 2
mesocricetus (2) 2
muscle, skeletal - blood supply (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 10/2010, Volume 299, Issue 4, pp. 1146 - 1152
Erythrocytes release ATP in response to exposure to the physiological stimulus of lowered oxygen (O2) tension as well as pharmacological activation of the... 
Red blood cell | Carbenoxolone | Iloprost | Cystic fibrosis transmembrane conductance regulator | Probenecid | probenecid | G-PROTEIN G(I) | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | iloprost | MAXI-ANION CHANNEL | RABBIT ERYTHROCYTES | red blood cell | carbenoxolone | TRANSMEMBRANE CONDUCTANCE REGULATOR | ADENOSINE-TRIPHOSPHATE | VOLUME REGULATION | HEMICHANNELS | cystic fibrosis transmembrane conductance regulator | MIMETIC PEPTIDES | PERIPHERAL VASCULAR DISEASE | RED-BLOOD-CELL | SIGNAL-TRANSDUCTION PATHWAY | Connexins - antagonists & inhibitors | Nerve Tissue Proteins - antagonists & inhibitors | Receptors, Prostaglandin - drug effects | Receptors, Epoprostenol | Iloprost - pharmacology | Humans | Middle Aged | Probenecid - pharmacology | Male | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Receptors, Prostaglandin - metabolism | Oxygen - metabolism | Connexins - metabolism | Erythrocytes - drug effects | Nerve Tissue Proteins - metabolism | Carbenoxolone - pharmacology | Epoprostenol - analogs & derivatives | Glyburide - pharmacology | Adenosine Triphosphate - metabolism | Erythrocytes - metabolism | Adult | Female | Care and treatment | Erythrocytes | Physiological aspects | Cystic fibrosis | Genetic aspects | Research | Adenosine triphosphate | Risk factors | Oxygen | T cell receptors | Kinases | Adenosine triphosphatase | Index Medicus
Journal Article
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2019
OBJECTIVESDescribe the clinical presentation, treatment, and outcomes of postsurgical thrombotic microangiopathy (TMA).METHODSIn this retrospective study,... 
Index Medicus
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2012, Volume 302, Issue 3, pp. 553 - 559
Erythrocytes have been implicated as controllers of vascular caliber by virtue of their ability to release the vasodilator ATP in response to local... 
Carbenoxolone | UT-15C | Iloprost | Bcl-X | Red blood cell | Isoproterenol | Tro19622 | BH4 | TRO19622 | G-PROTEIN G(I) | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | iloprost | isoproterenol | RABBIT ERYTHROCYTES | PLASMA-MEMBRANE | red blood cell | carbenoxolone | Bcl-x(L) BH4(4-23) | ADENOSINE-TRIPHOSPHATE | PLASMODIUM-FALCIPARUM | MITOCHONDRIAL CHANNEL | PERIPHERAL VASCULAR DISEASE | RED-BLOOD-CELLS | CELLULAR ATP | INDUCED INCREASES | SIGNAL-TRANSDUCTION PATHWAY | Connexins - antagonists & inhibitors | Antihypertensive Agents - pharmacology | Receptors, Epoprostenol | Iloprost - pharmacology | Humans | Middle Aged | Male | Receptors, Prostaglandin - metabolism | Young Adult | bcl-X Protein - pharmacology | Adenosine Triphosphate - metabolism | Adult | Epoprostenol - pharmacology | Female | Cyclic AMP - metabolism | Nerve Tissue Proteins - antagonists & inhibitors | Rabbits | Vasodilator Agents - pharmacology | Erythrocyte Membrane - metabolism | Voltage-Dependent Anion Channel 1 - metabolism | Adrenergic beta-Agonists - pharmacology | Erythrocyte Membrane - drug effects | Connexins - metabolism | Nerve Tissue Proteins - metabolism | Carbenoxolone - pharmacology | Epoprostenol - analogs & derivatives | Animals | Receptors, Prostaglandin - agonists | Signal Transduction - drug effects | Isoproterenol - pharmacology | Signal Transduction - physiology | Physiological aspects | Prostacyclin | Ion channels | Health aspects | Adenosine triphosphate | Erythrocytes | T cell receptors | Kinases | Adenosine triphosphatase | Index Medicus | Vascular Biology and Microcirculation | Bcl-xL BH44–23
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S329 - S330
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 02/2019, Volume 45, Issue 1, pp. 108 - 112
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 08/2008, Volume 295, Issue 2, pp. 786 - 793
Journal Article
The American Journal of the Medical Sciences, ISSN 0002-9629, 05/2019, Volume 357, Issue 5, pp. 411 - 420
The objective of this study was to describe presentation, natural history, management and long-term outcomes of patients with psychogenic purpura (PP), also... 
Ecchymosis | Autoerythrocyte | Psychogenic | Gardner-Diamond | Purpura | DIAGNOSIS | CELLS | AUTOSENSITIZATION | FORM | AUTO-ERYTHROCYTE SENSITIZATION | MEDICINE, GENERAL & INTERNAL | DISORDER | PATIENT | AUTOERYTHROCYTE SENSITIZATION SYNDROME
Journal Article
Journal of Immunological Methods, ISSN 0022-1759, 09/2018, Volume 460, pp. 63 - 71
Eculizumab (ECU) blocks complement C5 cleavage, preventing the formation of C5a and the cytolytic effects of the membrane attack complex. The presence of ECU... 
Soluble membrane attack complex | Eculizumab | Complement C5 component | Complement | Alternative pathway | C5 inhibitor | HEMOLYTIC-UREMIC SYNDROME | MAINTENANCE TREATMENT | FUNCTIONAL TESTS | BIOCHEMICAL RESEARCH METHODS | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | IMMUNOLOGY | DISCONTINUATION | INHIBITOR ECULIZUMAB | THERAPY | DISEASE | UPDATE | AHUS | Mass spectrometry | Analysis
Journal Article
Journal Article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S329 - S330
Conference Proceeding
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2010, Volume 298, Issue 2, pp. 587 - 593
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 05/2009, Volume 296, Issue 5, pp. 1617 - 1624
Activation of the G protein Gs results in increases in cAMP, a necessary step in the pathway for ATP release from rabbit and human erythrocytes. In all cells,... 
Red blood cell | Rolipram | Adenosine 3′, 5′-cyclic monophosphate | β-adrenergic receptors | Adenosine 5′-trisphophate | PROTEIN-KINASE-A | adenosine 5 '-trisphophate | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES | CARDIAC MYOCYTES | rolipram | red blood cell | CROSS-TALK | adenosine 3 ', 5 '-cyclic monophosphate | beta-adrenergic receptors | STIMULATED PHOSPHODIESTERASE | THERAPEUTIC AGENTS | PERIPHERAL VASCULAR DISEASE | ATP RELEASE | SIGNAL-TRANSDUCTION PATHWAY | PROSTACYCLIN ANALOGS | 3',5'-Cyclic-AMP Phosphodiesterases - metabolism | Rabbits | Up-Regulation | Iloprost - pharmacology | Species Specificity | Humans | Cyclic Nucleotide Phosphodiesterases, Type 2 - metabolism | Adrenergic beta-Agonists - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Erythrocyte Membrane - enzymology | Erythrocyte Membrane - drug effects | Erythrocytes - drug effects | Animals | Signal Transduction - drug effects | 3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors | Adenosine Triphosphate - metabolism | Isoproterenol - pharmacology | Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism | Erythrocytes - enzymology | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cyclic AMP - metabolism | Proteins | Adenosine triphosphatase | Cells | Erythrocytes | Index Medicus | 5′-cyclic monophosphate | adenosine 5′-trisphophate | adenosine 3
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 10593 - 10593
Conference Proceeding